Israel Englander’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Israel Englander’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-191,269	Closed	-$1.92M	–	6848
2023 Q4	$1.92M	Buy	191,269 +175,408	+1,106%	+$796K	﹤0.01%	3645
2023 Q3	$45.7K	Buy	+15,861	New	+$58K	﹤0.01%	5497
2022 Q2	–	Sell	-59,786	Closed	-$139K	–	7690
2022 Q1	$139K	Buy	+59,786	New	+$204K	﹤0.01%	6002
2021 Q2	–	Sell	-59,427	Closed	-$915K	–	7286
2021 Q1	$915K	Buy	+59,427	New	+$1.4M	﹤0.01%	4302

Israel Englander's GRCL Position: Q1 2024 in Review

Israel Englander sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 191,269 shares — an estimated $1.92M sold.

Israel Englander first reported a position in GRCL in Q1 2021 and held it in 4 quarters. The position peaked at $1.92M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Israel Englander reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Israel Englander sold 191,269 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $1.92M.
Israel Englander first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q1 2021 and held it in 4 quarters.
Israel Englander's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $1.92M in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.